Central Nervous System Melanoma

Central nervous system melanoma represents one of the most serious complications in melanoma patients, occurring when this aggressive skin cancer spreads to the brain or spinal cord, or rarely develops directly within the central nervous system itself.

Table of contents

• Understanding Central Nervous System Melanoma
• Disease Classification and Identification
• Types of CNS Melanoma
• What Causes CNS Melanoma
• How Common Is It
• Signs and Symptoms
• What to Expect

Understanding Central Nervous System Melanoma

Central nervous system melanoma refers to melanoma cancer affecting the brain, spinal cord, or the protective membranes surrounding them. Melanoma is a serious form of skin cancer that starts from cells called melanocytes, which produce the pigment that gives skin its color. These melanocytes originally come from special cells called neural crest cells during early development.^[1]

The condition can occur in two main ways. Most commonly, melanoma that began somewhere else in the body spreads to the central nervous system. This is called metastatic disease, meaning the cancer has traveled from its original location to a new site. Less commonly, melanoma can develop directly within the central nervous system itself as a primary tumor.^[2]

When melanoma spreads to the brain, it represents a major cause of illness and death in melanoma patients. Understanding how this happens and how it can be managed is crucial for improving patient outcomes.^[1]

Disease Classification and Identification

Primary melanoma of the CNS, Malignant melanoma of meninges

C70.9

C0349626

Types of CNS Melanoma

There are two main types of central nervous system melanoma. The first and most common type is metastatic melanoma, where cancer cells from a melanoma elsewhere in the body travel to the central nervous system. This accounts for the vast majority of CNS melanoma cases.^[1]

The second, much rarer type is primary CNS melanoma. This uncommon disease represents only 1% of all melanoma cases and just 0.07% of all brain tumors. Primary CNS melanoma arises from melanocytes that naturally exist in the leptomeninges, which are the delicate membranes covering the brain and spinal cord. During normal development, melanocytes migrate to various parts of the body including the skin, eyes, mucous membranes, and the leptomeninges of the central nervous system.^[4]

Primary CNS melanoma typically appears in the area around the spinal cord or high cervical region. The tumor is usually a darkly pigmented, solid mass that often contains areas of bleeding or dead tissue. It is composed of sheets of irregular cells with prominent centers and frequent cell division, and it tends to invade the surrounding brain tissue.^[2]

What Causes CNS Melanoma

Multiple factors can lead to the development of melanoma. Common causes include exposure to ultraviolet radiation from sunlight, indoor tanning, and a treatment called PUVA therapy. People with light skin pigmentation and poor tanning ability are at higher risk, as are those with certain genetic conditions like FAMM syndrome and atypical mole syndrome.^[1]

Having a personal or family history of melanoma increases risk. People with weakened immune systems due to HIV, lymphoma, or organ transplants are also more vulnerable. Certain medications, including TNF inhibitors and BRAF inhibitors, can increase melanoma risk.^[1]

Several specific risk factors increase the likelihood that melanoma will spread to the central nervous system. Being male and over 60 years old carries higher risk. Deep, invasive, or ulcerated primary melanoma lesions are more likely to spread to the CNS, as are certain types of melanoma growth patterns called acral, lentiginous, or nodular histology.^[1]

When more than three lymph nodes are involved, or when melanoma has already spread to other organs at diagnosis, the risk of CNS spread increases. Genetic changes such as BRAF and NRAS mutations, as well as activation of a cellular pathway called PI3K/AKT, are associated with higher risk of brain metastases. Elevated levels of a blood marker called LDH also indicate increased risk.^[1]

How Common Is It

Melanoma is becoming more common worldwide and is now the fifth leading cause of cancer in both men and women in the United States. While the number of new cases is rising, death rates are beginning to decrease, likely due to better screening programs. Melanoma is rare in children and teenagers, but becomes more common with increasing age. It occurs more frequently in people with white skin compared to those with black or Asian skin.^[1]

Brain metastases are a common complication, especially in advanced-stage melanoma. Melanoma is the third most common cause of brain metastases after lung and breast cancer, accounting for almost 10 percent of all brain metastases cases. Melanoma is also the third most frequent cancer to cause metastases in the central nervous system, following breast and lung cancers.^[6][7]

In patients with Stage III melanoma, about 15 percent develop brain metastases, mostly within the first three years after surgery. It is estimated that in about 50-60% of patients with advanced melanoma, the disease will eventually spread to the CNS. Central nervous system metastases are found in 7% of melanoma patients at the time of initial diagnosis. However, autopsy studies show that 75% of melanoma patients die with brain metastases, indicating that many cases go undetected during life.^[1][6]

Most brain metastases from melanoma occur in the upper part of the brain, with about 15 percent located in the lower portions. In 3% of patients diagnosed with melanoma metastasis in the CNS, doctors cannot find where the primary tumor started.^[1][6]

Signs and Symptoms

Brain metastases from melanoma can cause a wide variety of symptoms that differ greatly from person to person. They should be suspected in any melanoma patient who develops unusual neurological symptoms or changes in behavior. Many patients initially show no symptoms at all.^[1]

Most symptoms result from the growing metastases and inflammatory swelling around the lesions in the brain. The most common symptom is headache. When tumors develop inside the brain, they can cause symptoms related to increased pressure within the skull, such as persistent headaches, nausea, and vomiting.^[5]

Patients may experience specific neurological symptoms depending on where in the brain the metastases are located. These can include weakness in parts of the body, numbness, difficulty with coordination or balance, vision problems, seizures, or changes in mental status. Some patients may develop personality or behavioral changes that are noticed by family members.^[1]

When melanoma affects the spinal cord area, patients may present with back pain, muscle weakness, numbness, paralysis, or loss of bladder control. In cases of primary CNS melanoma affecting the brain, patients might experience horizontal double vision and progressive headache.^[2][4]

A particularly serious complication is leptomeningeal metastasis, where cancer spreads to the membranes surrounding the brain and spinal cord. This represents one of the most serious complications for melanoma patients and is associated with very poor outcomes.^[4]

What to Expect

The development of brain metastases in melanoma is associated with serious outcomes. Detection of lesions in the CNS is linked with poor prognosis, and CNS metastases lead to death in 20-50% of patients. Symptomatic brain lesions are the immediate cause of death in about 90-94% of patients who die from melanoma with CNS involvement.^[6]

According to historical data, the typical survival time after CNS metastasis diagnosis was 5 to 7 months. However, newer treatment methods have significantly improved outcomes for some patients. With modern treatments including targeted therapies and immunotherapy, some patients are living much longer, though outcomes vary greatly depending on many factors.^[6][11]

For patients with leptomeningeal metastases from primary CNS melanoma, the prognosis is extremely poor. One case report described a patient who survived 13 months after diagnosis with aggressive treatment combining radiotherapy and chemotherapy directly into the spinal fluid.^[4]

Several factors can influence outcomes. Patients who receive both local treatments directed at the brain (such as surgery or focused radiation) and systemic treatments (medications that work throughout the body) tend to have better survival. The size and number of brain metastases, whether they cause symptoms, and the patient’s overall health all play important roles in determining outcomes.^[11]

In the latest staging system from the American Joint Committee on Cancer, the presence of CNS metastases is now distinguished as a separate, final category in stage IV disease, recognizing its serious impact on patient outcomes.^[6]